SML2865

D5D-IN-326

≥98% (HPLC)

• Synonim(y): 2-(2,2,3,3,3-Pentafluoropropoxy)-3-[4-(2,2,2-trifluoroethoxy)phenyl]-5,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-4,6-dione, Compound-326
• Wzór empiryczny (zapis Hilla): C₁₇H₁₁F₈N₃O₄
• Numer CAS: 1236767-85-3
• Masa cząsteczkowa: 473.27
• UNSPSC Code: 51111800
• NACRES: NA.77
• MDL number: MFCD31813702
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: FC(F)(F)C(F)(F)COc1[n]([c](c3c([nH]c(c3)O)n1)=O)c2ccc(cc2)OCC(F)(F)F
• InChI: 1S/C17H11F8N3O4/c18-15(19,17(23,24)25)6-32-14-27-12-10(5-11(29)26-12)13(30)28(14)8-1-3-9(4-2-8)31-7-16(20,21)22/h1-5,26,29H,6-7H2
• InChI key: VKDOANVHEBFXOC-UHFFFAOYSA-N

Opis

Biochem/physiol Actions

D5D-IN-326 (Compound-326) is an orally available, potent and selective inhibitor of delta-5 desaturase (D5D) that reduces insulin resistance and body weight in a high-fat diet-induced obese mice. It appears that D5D-IN-326 significantly inhibits the progression of atherosclerosis in the aorta of western-diet fed ApoE knockout (KO) mice. It is called Compound-326 in recent J Pharmacol Exp Ther. 2019 Nov;371(2):290-298. (PMID: 31488602) paper.

orally available, potent and selective inhibitor of delta-5 desaturase (D5D)

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• Co się dzieje?: WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable